Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11377441 Covalent inhibitors of KRAS

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
June 29, 2020
Date of Patent
July 5, 2022
Patent Application Number
16915942
Patent Citations
‌
US Patent 10144724 Substituted quinazoline compounds and methods of use thereof
‌
US Patent 10723738 Inhibitors of KRAS G12C mutant proteins
‌
US Patent 10730867 Inhibitors of KRAS G12C mutant proteins
‌
US Patent 10736897 Compounds and methods of use thereof for treatment of cancer
‌
US Patent 10745385 Covalent inhibitors of KRAS
‌
US Patent 10822312 Substituted quinazoline compounds and methods of use
‌
US Patent 10829458 Substituted quinazoline compounds and methods of use thereof
‌
US Patent 10858343 Inhibitors of KRAS G12C mutant proteins
‌
US Patent 10875842 Inhibitors of KRAS G12C mutant proteins
‌
US Patent 10882847 Inhibitors of KRAS G12C mutant proteins
•••
Patent Citations Received
‌
US Patent 11639346 Quinazoline derivatives as modulators of mutant KRAS, HRAS or NRAS
0
‌
US Patent 12134620 Heterocyclic spiro compounds and methods of use thereof for the treatment of cancer
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11377441
Patent Primary Examiner
‌
Sarah Pihonak
CPC Code
‌
C07D 471/04
‌
C07D 487/04
‌
C07D 413/14
‌
C07B 2200/07
‌
C07D 405/14
‌
A61P 35/00
‌
C07D 401/14
‌
C07D 403/04
‌
C07D 417/14
‌
C07D 403/14

Find more entities like US Patent 11377441 Covalent inhibitors of KRAS

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.